NeuroSense Therapeutics Ownership | Who Owns NeuroSense Therapeutics?


OverviewFinancialsChart

NeuroSense Therapeutics Ownership Summary


NeuroSense Therapeutics is owned by 1.25% institutional investors, 25.43% insiders, and 73.32% retail investors. Meitav investment house is the largest institutional shareholder, holding 0.26% of NRSN shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.06% of its assets in NeuroSense Therapeutics shares.

NRSN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNeuroSense Therapeutics1.25%25.43%73.32%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Meitav investment house40.00K0.26%$44.80K
Xtx topco32.65K0.21%$36.57K
Geode capital management11.96K0.08%$13.40K
Morgan stanley1.50K0.01%$1.68K
Cwm1.00K0.01%$1.00K
Ubs group---
Renaissance---
Woodline partners lp---
Armistice capital---
Qube research---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Xtx topco32.65K0.00%$36.57K
Meitav investment house40.00K0.00%$44.80K
Renaissance---
Cwm1.00K-$1.00K
Ubs group---
Armistice capital---
Qube research---
Woodline partners lp---
Morgan stanley1.50K-$1.68K
Geode capital management11.96K-$13.40K

Top Buyers

HolderShares% AssetsChange
Xtx topco32.65K0.00%32.65K
Geode capital management11.96K--
Morgan stanley1.50K--
Cwm1.00K--
Qube research---54.00

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.58M
Renaissance---71.10K
Woodline partners lp---19.58K
Ubs group---11.93K
Meitav investment house40.00K0.00%-10.00K

New Positions

HolderShares% AssetsChangeValue
Xtx topco32.65K0.00%32.65K$36.57K

Sold Out

HolderChange
Qube research-54.00
Ubs group-11.93K
Woodline partners lp-19.58K
Renaissance-71.10K
Armistice capital-1.58M

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20247-225,356-86.52%11.06%4100.00%--100.00%
Jun 30, 20247-12.50%1,671,167899.94%10918.60%2-33.33%1-
Mar 31, 20248-167,12618.03%184.21%3-40.00%1-
Dec 31, 2023860.00%141,595-81.83%14.47%5150.00%1-
Sep 30, 20235-16.67%779,367-47.14%53.22%2-33.33%1-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index11.96K0.06%-

NRSN Ownership FAQ


Who Owns NeuroSense Therapeutics?

NeuroSense Therapeutics shareholders are primarily institutional investors at 1.25%, followed by 25.43% insiders and 73.32% retail investors. The average institutional ownership in NeuroSense Therapeutics's industry, Biotech Stocks , is 47.04%, which NeuroSense Therapeutics falls below.

Who owns the most shares of NeuroSense Therapeutics?

NeuroSense Therapeutics’s largest shareholders are Meitav investment house (40K shares, 0.26%), Xtx topco (32.65K shares, 0.21%), and Geode capital management (11.96K shares, 0.08%). Together, they hold 0.55% of NeuroSense Therapeutics’s total shares outstanding.

Does Blackrock own NeuroSense Therapeutics?

BlackRock is not among the top 10 institutional shareholders of NeuroSense Therapeutics.

Who is NeuroSense Therapeutics’s biggest shareholder by percentage of total assets invested?

Xtx topco is NeuroSense Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 32.65K NeuroSense Therapeutics shares, valued at 36.57K$.

Who is the top mutual fund holder of NeuroSense Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of NeuroSense Therapeutics shares, with 0.06% of its total shares outstanding invested in 11.96K NeuroSense Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools